Cargando…
Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA)
BACKGROUND: Docosahexaenoic acid (DHA) is a natural compound with anticancer and anti-angiogenesis activity that is currently under investigation as both a preventative agent and an adjuvant to breast cancer therapy. However, the precise mechanisms of DHA’s anticancer activities are unclear. It is u...
Autores principales: | Hannafon, Bethany N., Carpenter, Karla J., Berry, William L., Janknecht, Ralf, Dooley, William C., Ding, Wei-Qun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504101/ https://www.ncbi.nlm.nih.gov/pubmed/26178901 http://dx.doi.org/10.1186/s12943-015-0400-7 |
Ejemplares similares
-
Intercellular Communication by Exosome-Derived microRNAs in Cancer
por: Hannafon, Bethany N., et al.
Publicado: (2013) -
Plasma exosome microRNAs are indicative of breast cancer
por: Hannafon, Bethany N., et al.
Publicado: (2016) -
Fortification of pork loins with docosahexaenoic acid (DHA) and its effect on flavour
por: Meadus, William J, et al.
Publicado: (2013) -
SRSF1 regulates exosome microRNA enrichment in human cancer cells
por: Xu, Yi-Fan, et al.
Publicado: (2020) -
Sorafenib and docosahexaenoic acid act in synergy to suppress cancer cell viability: a role of heme oxygenase 1
por: Jiao, Yang, et al.
Publicado: (2018)